Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

7.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.2K
Inflammation01:38

Inflammation

55.1K
Overview
55.1K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

73
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SLC7A11 deficiency exacerbates systemic lupus erythematosus by inducing instability and ferroptosis in regulatory T cells.

Communications biology·2026
Same author

Nonlinear association between body mass index and physical fitness in primary school children: a single-school cross-sectional study using generalized additive models.

BMC pediatrics·2026
Same author

Corrigendum to "Exploring the mechanism of Sinisan in the treatment of ulcerative colitis with depression based on UPLC-Q-Orbitrap-MS combined with network pharmacology, molecular docking, and experimental validation" [J. Ethnopharmacol. (2025) (347) 119696].

Journal of ethnopharmacology·2026
Same author

Modulation of the mevalonate pathway by TCR engagement regulates T follicular helper cell generation in homeostasis and autoimmunity.

Immunity·2026
Same author

Comparing Pharmacist-Managed Warfarin Versus Usual Care in HeartMate 3 Patients: A Multicenter Retrospective Observational Study.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A Robust Biopolymer Network Binder for High-Loading Iodine Cathodes in Zinc-Iodine Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026

Related Experiment Video

Updated: Sep 12, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

Emodin Alleviates Sepsis-Induced Multiorgan Damage by Inhibiting NETosis through Targeting Neutrophils BCL-10.

Xiaolong Xu1, Yumeng Yan1,2, Meiling Zheng1

  • 1Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Chinese Medicine, Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing, 100010, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|August 8, 2025
PubMed
Summary

Emodin, a natural compound, effectively treats sepsis by inhibiting neutrophil extracellular traps (NETs) formation. It targets BCL-10, modulating the BCL-10/MALT1 complex to reduce inflammation and protect organs.

Keywords:
BCL‐10/MALT1EmodinNETosisNF‐κBsepsis

More Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.2K

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Sepsis involves excessive inflammation and abnormal coagulation.
  • Neutrophil extracellular traps (NETs) link inflammation and coagulation in sepsis.
  • Emodin, from Dahuang, is a potential therapeutic agent.

Purpose of the Study:

  • To investigate Emodin's therapeutic effects on sepsis.
  • To identify Emodin's molecular target in sepsis.
  • To elucidate the mechanism of Emodin's action.

Main Methods:

  • In vivo and in vitro sepsis models.
  • Protein microarrays, SPR, pull-down assays, molecular docking.
  • Conditional BCL-10 knockout in neutrophils, single-cell sequencing.

Main Results:

  • Emodin ameliorates sepsis-induced cytokine storm and coagulation abnormalities.
  • Emodin directly targets BCL-10, inhibiting NETs formation.
  • BCL-10 promotes excessive NET formation in sepsis.
  • Emodin modulates the BCL-10/MALT1 complex, suppressing NF-κB activation.

Conclusions:

  • Emodin targets BCL-10 to regulate the BCL-10/MALT1 complex and NF-κB signaling.
  • Emodin confers significant multiorgan protection in sepsis.
  • Findings support Emodin's translational research potential for sepsis treatment.